RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
…
Rockwood Research

Corporate filings · Event Monitor · Free for all

← Back

Rapport Therapeutics, Inc.

RAPP

Pharmaceutical Preparations · SIC 2834 · CIK 0002012593

SHARE:XLINKEDINEMAIL
Revenue FY2025
—
Net Income
$(111.0M)
EPS (Basic)
$-2.86
Net Margin
—
ROE
-23.0%
Total Equity
$485.0M
Shares Out
48M

Rapport Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 5 funds in our universe

FundPosition Value% of AUMQoQ ChgWeight
Baker Bros. Advisors
Baker Bros. Advisors
$64.5M
0.2%
—
OrbiMed Advisors
OrbiMed Advisors
$3.2M
0.0%
NEW
Adage Capital Management
Adage Capital Management
$6.3M
0.0%
—
Alps Advisors
Alps Advisors
$2.0M
0.0%
+24.0%
Capital World Investors
Capital World Investors
$23.0M
0.0%
+2.8%

Insider Transactions

Reading stored insider transactions…